search
Company Information
USD
1.36
- (-%)
NASDAQ:PSNL, PERSONALIS, INC.
Industry: Diagnostics & Research
End of Day: 14 June 2024 GMT-4
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Address

6600 Dumbarton Circle

Classification

Sector

Healthcare

Industry Group

Medical Diagnostics & Research

Industry

Diagnostics & Research

Key Executives

Mr. Aaron L. Tachibana
CFO/Chief Accounting Officer/COO
Mr. A. Blaine Bowman
Director
Mr. Christopher Hall
CEO/Director/President
Ms. Karin Eastham
Chairman of the Board/Director
Dr. Woodrow A. Myers, Jr,M.D.
Director
Ms. Lonnie Shoff
Director
Ms. Olivia K. Bloom
Director
Mr. Stephen M. Moore
General Counsel/Secretary/Vice President
Mr. Kenneth J. Widder, M.D.
Director
Dr. Richard Chen, M.D.,M.S.
Chief Medical Officer/Executive VP, Divisional

Ownership

Institution Holdings

ARK Investment Management LLC
6,671,545 (13.210%)
BlackRock Inc
3,315,268 (6.564%)
Vanguard Group Inc
2,070,094 (4.099%)
Vanguard Investments Australia Ltd
1,375,373 (2.723%)
Alyeska Investment Group, L.P.
1,245,668 (2.466%)
Nikko Asset Management Americas Inc
1,083,685 (2.146%)
Sumitomo Mitsui Trust Holdings Inc
1,083,685 (2.146%)
Nikko Asset Management Co Ltd
923,980 (1.830%)
BlackRock Advisors LLC
891,042 (1.764%)
Renaissance Technologies Corp
840,811 (1.665%)

Funds Holdings

ARK Genomic Revolution
6,612,566 (13.093%)
ARK Genomic Revolution ETF
5,500,860 (10.892%)
BlackRock Advantage Small Cap Core Fund
679,753 (1.346%)
Blackrock Russell 2000 Alpha Tilts
164,900 (0.327%)
BlackRock Advantage SMID Cap Fund, Inc.
150,516 (0.298%)
BlackRock Advantage Small Cap Growth Fd
127,989 (0.253%)
BlackRock Advantage SMID Cap V.I. Fd
83,300 (0.165%)
BlackRock Extended Equity Market
69,204 (0.137%)
Fidelity Series Total Market Index Fund
52,496 (0.104%)
NT DJ US Complt Ttl Stk Mkt Idx Eq Strat
39,508 (0.078%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices